{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:52:38Z","timestamp":1790790758198,"version":"4.1.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background and aims<\/jats:title>\n                    <jats:p>Acute rejection (AR) is a common complication after liver transplantation. Current diagnostic modalities for acute rejection are either invasive or lack sufficient sensitivity. Therefore, the present study aimed to develop a novel and sensitive diagnostic tool for predicting AR after liver transplantation. Specifically, we investigated whether serum donor-derived cell-free DNA (dd-cfDNA) is closely associated with the occurrence of post-transplant AR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A prospective single-center diagnostic study enrolled 40 primary whole liver transplant recipients, divided into an indicative biopsy cohort (abnormal liver function requiring biopsy) and a protocol biopsy cohort (stable\/mildly abnormal liver function without biopsy indication). The dd-cfDNA levels (absolute copy number and relative quantification) were dynamically monitored 14 days to 1 year post-transplant. Using pathological biopsy as the gold standard, receiver operating characteristic (ROC) curve analysis and logistic regression models compared the diagnostic efficacy of dd-cfDNA and liver function indices for AR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our study demonstrated that circulating dd-cfDNA levels were significantly elevated in liver transplant recipients with acute rejection (AR) compared to those without. The diagnostic cutoffs were determined as dd-cfDNA% \u226510.39% (sensitivity: 95%, specificity: 90%) and dd-cfDNA \u22651928 copies\/mL (sensitivity: 70%, specificity: 90%). The area under the curve (AUC) for dd-cfDNA% was 0.940, and for dd-cfDNA was 0.823, both outperforming routine liver function tests. After effective anti-rejection therapy, dd-cfDNA levels rapidly decreased, correlating with clinical improvement, as well as improvements in liver function and histopathology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>As a sensitive and non-invasive biomarker, dd-cfDNA can effectively predict the occurrence of AR after liver transplantation. Moreover, changes in dd-cfDNA levels facilitate the assessment of therapeutic efficacy, providing crucial references for optimizing immunosuppressive regimens and improving patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1769538","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T04:26:20Z","timestamp":1778473580000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Donor-derived cell-free DNA as a noninvasive biomarker for diagnosis and monitoring of acute rejection after liver transplantation"],"prefix":"10.3389","volume":"17","author":[{"given":"Zhigao","family":"Deng","sequence":"first","affiliation":[{"name":"Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, National Quality Control Center for Donated Organ Procurement, Hubei Key Laboratory of Medical Technology on Transplantation, Hubei Provincial Clinical Research Center for Natural Polymer Biological Liver","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meicheng","family":"Yang","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, National Quality Control Center for Donated Organ Procurement, Hubei Key Laboratory of Medical Technology on Transplantation, Hubei Provincial Clinical Research Center for Natural Polymer Biological Liver","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanwei","family":"Cheng","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, National Quality Control Center for Donated Organ Procurement, Hubei Key Laboratory of Medical Technology on Transplantation, Hubei Provincial Clinical Research Center for Natural Polymer Biological Liver","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongshan","family":"Lu","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, National Quality Control Center for Donated Organ Procurement, Hubei Key Laboratory of Medical Technology on Transplantation, Hubei Provincial Clinical Research Center for Natural Polymer Biological Liver","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifa","family":"Ye","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, National Quality Control Center for Donated Organ Procurement, Hubei Key Laboratory of Medical Technology on Transplantation, Hubei Provincial Clinical Research Center for Natural Polymer Biological Liver","place":["Wuhan, Hubei, China"]},{"name":"NHC Key Laboratory of Translational Research on Transplantation Medicine, The 3rd Xiangya Hospital of Central South University","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xiong","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, National Quality Control Center for Donated Organ Procurement, Hubei Key Laboratory of Medical Technology on Transplantation, Hubei Provincial Clinical Research Center for Natural Polymer Biological Liver","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojun","family":"Ye","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, National Quality Control Center for Donated Organ Procurement, Hubei Key Laboratory of Medical Technology on Transplantation, Hubei Provincial Clinical Research Center for Natural Polymer Biological Liver","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.hbpd.2022.12.001","article-title":"State of the art and perspectives in liver transplantation","volume":"22","author":"Xu","year":"2023","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2024.01176","article-title":"Recent trends and new developments in liver transplantation","volume":"18","author":"Sugawara","year":"2024","journal-title":"Biosci Trends"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000873","article-title":"The future of liver transplantation","volume":"80","author":"Feng","year":"2024","journal-title":"Hepatology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.70349","article-title":"Survival outcomes of liver transplantation amid rising recipient and donor risk profiles","volume":"39","author":"Ashwat","year":"2025","journal-title":"Clin Transplant"},{"key":"B5","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.cgh.2016.07.035","article-title":"Acute rejection increases risk of graft failure and death in recent liver transplant recipients","volume":"15","author":"Levitsky","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/lt.25812","article-title":"Genomics and liver transplantation: Genomic biomarkers for the diagnosis of acute cellular rejection","volume":"26","author":"Kohut","year":"2020","journal-title":"Liver Transpl"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.01.030","article-title":"Liver transplantation immunology: Immunosuppression, rejection, and immunomodulation","volume":"78","author":"Montano-Loza","year":"2023","journal-title":"J Hepatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01044","article-title":"Transplant tolerance induction: Insights from the liver","volume":"11","author":"Dai","year":"2020","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4103\/ijpm.ijpm_1090_21","article-title":"Liver transplant biopsy interpretation: Diagnostic considerations and conundrums","volume":"65","author":"Rastogi","year":"2022","journal-title":"Indian J Pathol Microbiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100439","article-title":"Nucleic acid biomarkers to assess graft injury after liver transplantation","volume":"4","author":"Bardhi","year":"2022","journal-title":"JHEP Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13104-022-06268-w","article-title":"Clinical and financial impacts of abnormal liver biochemistry after liver transplantation","volume":"16","author":"Lim","year":"2023","journal-title":"BMC Res Notes"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000002482","article-title":"Donor-specific cell-free DNA as a biomarker in solid organ transplantation. A systematic review","volume":"103","author":"Knight","year":"2019","journal-title":"Transplantation"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/js9.0000000000002358","article-title":"Diagnostic and predictive biomarkers of acute rejection after liver transplantation","volume":"111","author":"Pan","year":"2025","journal-title":"Int J Surg"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2021-0968","article-title":"Cell-free DNA as a solid-organ transplant biomarker: Technologies and approaches","volume":"16","author":"Edwards","year":"2022","journal-title":"biomark Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2024.12.003","article-title":"Absolute quantification of cell-free DNA for prenatal genetics and oncology","volume":"43","author":"Tsao","year":"2025","journal-title":"Trends Biotechnol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002286","article-title":"Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study","volume":"14","author":"Sch\u00fctz","year":"2017","journal-title":"PloS Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117647","article-title":"Development and performance of a next generation sequencing (NGS) assay for monitoring of dd-cfDNA post solid organ transplantation","volume":"552","author":"Pettersson","year":"2024","journal-title":"Clin Chim Acta"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0282332","article-title":"Droplet digital PCR-based testing for donor-derived cell-free DNA in transplanted patients as noninvasive marker of allograft health: Methodological aspects","volume":"18","author":"Clausen","year":"2023","journal-title":"PloS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41581-021-00428-0","article-title":"Liquid biopsies: Donor-derived cell-free DNA for the detection of kidney allograft injury","volume":"17","author":"Oellerich","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1031894","article-title":"Donor-derived cell-free DNA as a diagnostic tool in transplantation","volume":"13","author":"Oellerich","year":"2022","journal-title":"Front Genet"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13121982","article-title":"All that glitters in cfdna analysis is not gold or its utility is completely established due to graft damage: A critical review in the field of transplantation","volume":"13","author":"Jim\u00e9nez-Coll","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03087-3","article-title":"Cell-free DNA for the detection of kidney allograft rejection","volume":"30","author":"Aubert","year":"2024","journal-title":"Nat Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2020.100590","article-title":"Noninvasive biomarkers for prediction and diagnosis of heart transplantation rejection","volume":"35","author":"Khachatoorian","year":"2021","journal-title":"Transplant Rev (Orlando)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2022.10546","article-title":"Validation of a simple, rapid, and cost-effective method for acute rejection monitoring in lung transplant recipients","volume":"35","author":"Sorbini","year":"2022","journal-title":"Transpl Int"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/mot.0000000000000924","article-title":"Progress and challenges in diagnosis and treatment of rejection following liver transplantation","volume":"26","author":"Cuervo Florez","year":"2021","journal-title":"Curr Opin Organ Transplant"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13909","article-title":"2016 comprehensive update of the Banff Working Group on liver allograft pathology: Introduction of antibody-mediated rejection","volume":"16","author":"Demetris","year":"2016","journal-title":"Am J Transplant"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.07.027","article-title":"Antibody-mediated rejection of the liver allograft: An update and a clinico-pathological perspective","volume":"75","author":"Lee","year":"2021","journal-title":"J Hepatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.647900","article-title":"Sensing acute cellular rejection in liver transplant patients using liver-derived extracellular particles: A prospective, observational study","volume":"12","author":"Kamali","year":"2021","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trim.2018.02.002","article-title":"Non invasive diagnosis of acute cellular rejection after liver transplantation - Current opinion","volume":"47","author":"Kumar","year":"2018","journal-title":"Transpl Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16835","article-title":"Donor-derived cell-free DNA levels predict graft injury in liver transplant recipients","volume":"22","author":"Levitsky","year":"2022","journal-title":"Am J Transplant"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13978","article-title":"Noninvasive graft monitoring using donor-derived cell-free DNA in Japanese liver transplantation","volume":"54","author":"Kanamori","year":"2024","journal-title":"Hepatol Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/s41598-020-80845-6","article-title":"Preliminary clinical experience applying donor-derived cell-free DNA to discern rejection in pediatric liver transplant recipients","volume":"11","author":"Zhao","year":"2021","journal-title":"Sci Rep"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/lt.26272","article-title":"Monitoring of donor-derived cell-free DNA by short tandem repeats: Concentration of total cell-free DNA and fragment size for acute rejection risk assessment in liver transplantation","volume":"28","author":"Fern\u00e1ndez-Gal\u00e1n","year":"2022","journal-title":"Liver Transpl"},{"key":"B34","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12893-025-02911-y","article-title":"Advances and challenges in the application of donor-derived cell-free DNA for diagnosis and treatment in liver transplantation: A narrative review","volume":"25","author":"Zhong","year":"2025","journal-title":"BMC Surg"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2023.11507","article-title":"Assessment of donor derived cell free DNA (dd-cfDNA) at surveillance and at clinical suspicion of acute rejection in renal transplantation","volume":"36","author":"Mantios","year":"2023","journal-title":"Transpl Int"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2025.04.024","article-title":"Absolute quantification of donor-derived cell-free DNA following pediatric and adult heart transplantation","volume":"44","author":"B\u00f6hmer","year":"2025","journal-title":"J Heart Lung Transplant"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s40472-021-00349-8","article-title":"Donor-derived cell-free DNA for acute rejection monitoring in heart and lung transplantation","volume":"8","author":"Keller","year":"2021","journal-title":"Curr Transplant Rep"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2025.102307","article-title":"Diagnostic value of dd-cfDNA and CXCL-10 in kidney allograft recipients for identifying acute rejection","volume":"93","author":"Yu","year":"2025","journal-title":"Transpl Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14258","article-title":"Single-center utilization of donor-derived cell-free DNA testing in the management of heart transplant patients","volume":"35","author":"Gondi","year":"2021","journal-title":"Clin Transplant"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1604200","article-title":"Donor-derived cell-free DNA and miRNA monitoring for the early prediction and diagnosis of liver allograft rejection and patient outcomes","volume":"16","author":"Julian","year":"2025","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1769538\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T04:26:22Z","timestamp":1778473582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1769538\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":40,"alternative-id":["10.3389\/fimmu.2026.1769538"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1769538","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"article-number":"1769538"}}